ARTICLE | Clinical News
Afstyla regulatory update
November 17, 2016 2:34 PM UTC
EMA's CHMP recommended approval of Afstyla lonoctocog alfa from CSL for the treatment and prophylaxis of bleeding in patients with hemophilia A. The recombinant coagulation single-chain Factor VIII (r...
BCIQ Company Profiles